Peppermint Bloating Meta-analysis: What the Evidence Says

Quick Answer

Peppermint Bloating Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction characterized by recurrent abdominal pain associated with altered bowel habits, in the absence of identifiable structural abnormalities. [Šuran Jelena (2026); evidence level 3]
• Early studies reported SIBO in up to 60-78% of IBS cases based on lactulose breath testing, though later investigations using more rigorous methods found lower prevalences (e.g., 4-20%). [Šuran Jelena (2026); evidence level 3]
• Irritable bowel syndrome (IBS) is a chronic and prevalent disorder of gut-brain interaction, defined by recurrent abdominal pain associated with changes in stool frequency and/or form, in the absence of structural abnormalities. [Sacco Rodolfo (2026); evidence level 4]
• This conceptual shift aligns with clinical evidence showing that abdominal pain is not only diagnostic but also the most burdensome symptom reported by patients. [Sacco Rodolfo (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For peppermint bloating meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Šuran Jelena (2026). IBS and SIBO: Gut Microbiota, Pathophysiology, and Non-Pharmacological Interventions. DOI: 10.3390/antibiotics15030251. PMCID: PMC13023761. PMID: 41892413. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13023761/
• Sacco Rodolfo (2026). Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone. DOI: 10.3390/jcm15020722. PMCID: PMC12842271. PMID: 41598660. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12842271/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.